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Abstract
Objectives Patient activation covers the skills, abilities and behaviour that impact how able and will-
ing someone is to take an active role in self-managing their health. This study explored clinical and
psychosocial factors associated with patient activation in rheumatology patients.
Methods This was a cross-sectional study using postal survey methods. Participants with inflamma-
tory rheumatic conditions were from six rheumatology centres in England. Patient activation was cap-
tured using the Patient Activation Measure (PAM). Twenty-nine explanatory factors were tested for po-
tential association with patient activation in univariable and multivariable analyses. In preliminary
multivariable analyses, factors found to have an association with patient activation at a P< 0.1 level
were entered into the final multivariable model. Those that remained significant at a P< 0.05 level were
considered associated with patient activation.
Results The sample comprised 251 participants (74% female) with a mean age of 59.31 years (S.D.
12.69), disease duration of 14.48 years (S.D. 12.52) and a PAM score of 58.3 (S.D. 11.46). Of the 29 candi-
date factors, 25 were entered into a preliminary multivariable analysis. In the final multivariable analysis,
four factors (self-efficacy, the illness belief that treatment will control participants’ condition and two
dimensions of health literacy) were significantly associated with patient activation. This final model
accounted for 40.4% of the variance in PAM scores [F(4, 246)¼ 41.66, P< 0.001].
Conclusions Patient activation is important in managing rheumatic conditions. Our data confirm that
self-efficacy and health literacy are particular targets for patient activation interventions.
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Key messages
. Patients with inflammatory arthritis have a range of patient activation abilities and these should be considered
when designing self-management support.
. This is the first study to investigate factors associated with patient activation in UK rheumatology patients.
. Self-efficacy and health literacy are significantly associated with patient activation and key to developing patient
activation interventions.
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Inflammatory arthritis (IA) is an umbrella term that
includes several long-term conditions including RA, PsA
and AS. Symptoms often include pain, fatigue, joint stiff-
ness and swelling and issues such as psychological dis-
tress [1]. These are long-term conditions that require
self-management to cope with the physical and psycho-
social consequences of the conditions, as well as mak-
ing treatment decisions and managing complex
medication regimes.
IA is often managed in hospital settings with specialist
rheumatology teams. However, research into long-term
conditions in the UK suggests that patients spend ap-
proximately 5 hours ayear in consultations with health-
care professionals and remaining hours self-managing
[2]. This leaves patients with a great deal of responsibil-
ity for their own condition.
A concept that is closely related to self-management is
patient activation. Patient activation incorporates the skills,
abilities and behaviours that contribute to how able and
willing someone is to take an active role in managing his/
her health [3]. Where patient activation is high, patients are
confident and proactive in managing their health, seeking
information when required to make decisions about their
health and carrying out positive health-related behaviours
[4]. Alternatively, when patient activation is low, people are
passive, unable or unwilling to take responsibility for man-
aging their health. They are often very dependent on
healthcare professionals for information and direction. On a
healthcare system level, higher levels of activation are as-
sociated with fewer emergency admissions, fewer days as
an inpatient and lower healthcare costs [4]. On an individ-
ual level, increased activation is associated with better
physical and psychosocial outcomes, including more fre-
quent exercise, increased self-efficacy and lower rates of
depression [5, 6]. Therefore there is value in understanding
variables related to patient activation.
Patient activation is most commonly captured using
the Patient Activation Measure (PAM), a commercially li-
cenced measure that categorizes patients into one of
four activation levels ranging from 1 (passive) to 4 (ac-
tively managing their health) [7, 8]. It also provides
patients with a score up to 100, with higher scores indi-
cating more skilled and active self-management. It has
been used internationally and translated into more than
28 languages [9, 10]. It is intended for use in a range of
environments and conditions to tailor and evaluate self-
management support [7, 11].
The prevailing model of patient activation [12] sug-
gests positive and negative affect (underlying internal
feelings) contribute to patients’ activation via their com-
fort and confidence to carry out small behaviour
changes related to their health. This model was not de-
veloped with any specific long-term conditions as a fo-
cus. It was also not clear how many, if any, participants
in this study had a rheumatic condition. Due to this lack
of evidence regarding rheumatology patients in particu-
lar, this present study was needed.
Surveys in multiple sclerosis, diabetes and chronic
obstructive pulmonary disease (COPD) have identified
factors commonly associated with patient activation in
those conditions, including illness perceptions, anxiety,
participants’ knowledge about their condition, engage-
ment with routine check-ups and positive health behav-
iours [13–17]. In rheumatology, there was one study
conducted in Brazil that included patient activation in a
quest to assess factors associated with functional dis-
ability [18]. The same study found that high patient acti-
vation was negatively associated with functional
disability as measured by the HAQ [19].
Initial qualitative research with a sample of UK
patients with rheumatic conditions suggested concepts
that might be associated with patient activation [20].
These included self-efficacy (the belief that one can
achieve a desired outcome or goal), health literacy (skills
related to comprehending and evaluating health-related
information to make health-related decisions as well as
the ability to navigate health services to obtain the sup-
port needed to self-manage) [21, 22] and illness beliefs
(expectations about the nature and severity of one’s
condition and its treatment) [23].
The purpose of this study was to understand whether
these psychosocial variables contribute to patient acti-
vation in UK rheumatology patients, as there is limited
research on factors associated with patient activation in
this population. This is important because it is possible
there are rheumatology-specific variables that can in-
form theory-led patient activation interventions tailored
to the needs of this group.
Methods
Design
This was a multisite cross-sectional study using survey
methods. The survey pack was designed by B.J. (doc-
toral student with a psychology background) with input
from multiple perspectives including patient perspec-
tives (A.H.), a nurse researcher (M.N.) and academic
psychologists (D.H. and E.D.). Candidate factors (ex-
planatory variables) were identified based on their prom-
inence in the patient activation literature, including
qualitative research with skilled self-managers [20].
Measures used in the survey pack were chosen for their
psychometric properties, prior use in research with rheu-
matology patients, and minimal participant burden.
Ethics approval
The research was conducted in compliance with the
Declaration of Helsinki. Ethics approval to carry out this
research was granted by the Yorkshire and Humber
South Yorkshire Research Ethics Committees (reference
18/YH/0227) and ratified by the University of the West of
England (reference HAS.18.06.191). Consent to partici-
pate in the research was presumed based on partici-
pants having completed and returned the anonymous
questionnaire survey pack.













The opportunity sample of participants was recruited
from six rheumatology departments in England between
July and October 2018 and data collection took place
until July 2019. Predetermined sample characteristics
were not specifically sought but the intention was to
capture a range of participants using multiple recruit-
ment sites. The inclusion criteria were age >18 years,
living with an inflammatory rheumatic condition (includ-
ing RA, PsA and AS) or SLE because of the shared
experiences between SLE and IA, a patient at a recruit-
ing site and the ability to read and write in English.
Data collection and measures
Eligible patients were either approached in clinics and
invited to participate in the research or they were invited
to join via packs sent in the post with a cover letter and
information sheet. There were no alternative versions of
the survey with outcome measures in different orders to
reduce order effects. To ensure anonymity, packs were
coded and recruiting sites kept a record of which patient
was given which code. Completed pseudo-anonymized
packs were returned directly to B.J.
Patient activation (outcome variable) was measured
using the short form Patient Activation Measure (PAM)
[8]. The 13-item version of the measure was used and
participants are able to respond to the items with ‘dis-
agree strongly’, ‘disagree’, ‘agree’, ‘agree strongly’ or
‘N/A’. The PAM provides patients with the score (be-
tween 0 and 100), with higher scores indicating more
skilled and active self-management. The items in this
measure and further details about its development are
discussed elsewhere [8].
The candidate factors tested for association with pa-
tient activation were physical disability, self-efficacy,
health beliefs, health locus of control (HLOC), health lit-
eracy, affect, fatigue and pain.
Physical disability
Physical disability was measured using the HAQ [19].
The scores range between 0 and 3, with higher scores
reflecting a high level of disability.
Self-efficacy
Self-efficacy was measured by the RA Self Efficacy
Scale (RASE) [24], a 28-item measure developed to cap-
ture self-efficacy in British rheumatology patients. Final
scores range from 28 to 140, with higher scores indicat-
ing higher self-efficacy.
Health beliefs
The Brief Illness Perceptions Questionnaire (BIPQ) [25]
captures participants’ understanding of the timeline
and nature of their condition in nine domains. These
cover perceptions of consequences of their condition,
perceived timeline, personal control over the condition,
perceived treatment control over their condition, iden-
tity (covering experience of symptoms), illness concern,
coherence (i.e., understanding) of illness and emotional
impact of their condition. The personal control,
treatment control and coherence domains are calcu-
lated so that lower scores indicate more threatening
views of the condition and higher scores in the other
domains represent more threatening perceptions of
their condition [26].
Health locus of control (HLOC)
The HLOC [26] relates to what extent individuals feels
that outcomes related to their health occur because of
actions that they can take charge of (internal locus of
control) or because of variables that are outside of their
control (external locus of control). Form C of the multidi-
mensional HLOC scale [27] includes 18 items and cap-
tures participants’ beliefs about how much of their
condition is impacted by their personal actions or other
determinants. The items’ phrasing allows for a specific
condition to be named to personalize it for participant
groups. The four subscales are internal (self), chance,
doctors and powerful others. The higher the score on
each subscale, the higher the participants’ type of locus
of control. The subscales for doctors and powerful
others have a range of 3–18. The internal and chance
subscales have ranges from 6 to 36.
Health literacy
The Health Literacy Questionnaire [28] is a 44-item mea-
sure that captures participants’ abilities to navigate the
healthcare system confidently, to gather and apply
health-related information and to work with healthcare
providers. There are nine total domains capturing vari-
ous dimensions of health literacy:
1. Feeling understood and supported by my healthcare
provider
2. Having sufficient information to manage my health
3. Actively managing my health
4. Social support for health
5. Appraisal of health information
6. Ability to actively engage with healthcare providers
7. Navigating the healthcare system
8. Ability to find good health information
9. Understanding health information enough to know
what to do
Participants are presented with statements to respond
to and scores for the first five domains range from 1
(strongly disagree) to 4 (strongly agree). For the last four
domains the scores range from 1 (cannot do/always dif-
ficult) to 5 (always easy). Mean scores for each domain
are calculated based on the participants’ responses to
the items in the subscales. The higher the score, the
higher the health literacy participants have.
Affect
The Positive and Negative Affect Scale (PANAS) is a 20-
item measure (10 items each) that was selected be-
cause of its use in prior patient activation research [12,
29]. It provides a separate score for both positive and
negative affect ranging between 0 and 50. The higher
the score, the greater the positive or negative affect the
participant has experienced recently.













A numerical rating scale (NRS) [30] from the Bristol RA
Fatigue Scale (BRAF) captures average fatigue levels
over the previous 24 h. Scores range from 0 to 10, with
higher scores reflecting more debilitating fatigue.
Pain
The pain NRS captures average levels of pain over the
last 24 h. Scores range from 0 to 10, with higher scores
reflecting more debilitating pain.
Patient involvement
A patient research partner (A.H.) was part of the study
team. He offered his perspective on the study design
(including study documentation), the constructs being
captured, the outcome measures included and the for-
mat of the survey pack. He piloted the survey pack to
review it for clarity and length.
Sample size
A sample size estimation was based on the requirement
for multiple regression analysis using the formula
50þ 8m, where m is the number of explanatory varia-
bles [31]. The number of explanatory variables in this
study was 29 (accounting for the continuous demo-
graphic data, all outcome measures and any relevant
subscales used as factors), therefore the sample size
estimate was 282.
Analysis
Exploring factors associated with patient activation in
participants requires understanding what proportion of
the variance in PAM scores can be explained by the
variables included in the regression models. Incomplete
responses (missing one full demographic factor or one
full outcome measure) were excluded in the analysis. If
one item in the measures was missing, it was imputed
by using an average score of other items in the measure
or subscale. If more than one item was missing in a
measure, it was excluded. Descriptive statistics were
calculated for all continuous variables. For categorical
variables, the frequencies of responses were calculated.
To begin with, it was necessary to understand what
variables were significantly associated with the PAM
scores. For this reason, candidate variables for the mul-
tiple regression were identified using univariable analy-
ses by testing the relationships between PAM scores
and each of the candidate variables. Those variables
without a significant correlation with PAM scores were
removed from the candidate variables for the regression
analysis. Once candidate variables were identified, a
preliminary multiple regression analysis was conducted
with the PAM scores as the outcome variable. Variables
that were statistically significant with a P-value <0.1
were included in a final multiple regression model. The
parameter estimates (B) are presented with the corre-
sponding 95% CIs and P-values for variables that were
TABLE 1 Characteristics of participants
Characteristics Values
Sex, n (%) Female, 185 (74)
Male, 66 (26.3)
Ethnicity, n (%) White British, 235 (94)
Other white, 8 (3)
Black, 1 (<1)
Chinese, 1 (<1)
Other Asian, 2 (<1)
Other, 3 (1)
Prefer not to say, 1(<1)








Don’t know, 3 (1)
Age, years, mean (S.D.) 59.31 (12.69)
Disease duration, years, mean (S.D.) 14.48 (12.52)
Patient activation (PAM; range
0–100), mean (S.D.)
58.3 (11.46)
Physical disability (HAQ; range
0–3), mean (S.D.)
0.75 (0.65)
Self-efficacy (RASE; range 28–140),
mean (S.D.)
101.61 (15.24)
Health beliefs (BIPQ), mean (S.D.)
Consequences (range 0–10) 6.26 (2.30)
Timeline (range 0–10) 9.53 (1.13)
Personal control (range 0–10) 4.92 (2.26)
Treatment control (range 0–10) 7.41 (1.93)
Identity (range 0–10) 6.52 (2.12)




Illness concern (range 0–10) 6.91 (2.47)
HLOC, mean (S.D.)
Internal (range 6–36) 16.98 (6.14)
Chance (range 6–36) 16.33 (6.47)
Doctors (range 3–18) 11.31 (3.23)
Powerful others (range 3–18) 8.71 (3.57)
Health literacy (HLQ), mean (S.D.)
Feeling understood (range 1–4) 2.96 (0.71)
Sufficient information (range 1–4) 2.91 (0.48)
Actively managing (range 1–4) 2.89 (0.47)
Social support (range 1–4) 2.92 (0.57)
Appraisal (range 1–4) 2.68 (0.53)
Ability to engage (range 1–5) 3.78 (0.73)
Navigating healthcare (range 1–
5)
3.59 (0.66)
Ability to find information (range
1–5)
3.83 (0.63)
Knowing what to do (range 1–5) 4.08 (0.55)
Positive affect (PANAS; range
0–50)
30.03 (8.85)
Negative affect (PANAS; range
0–50)
19.88 (7.73)
Fatigue severity (NRS; range
0–10)
6.43 (2.28)
Pain severity (NRS; range 0–10) 5.43 (2.51)
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significant at a¼ 0.05 are interpreted as factors signifi-
cantly associated with patient activation. All analyses
were conducted using SPSS 25 for Windows (IBM,
Armonk, NY, USA).
Results
A total of 267 patients participated. Seven were ex-
cluded due to missing data on any outcome measures
or demographic variables and nine were excluded due
to completing outcome measures in ways that invali-
dated them (e.g., completing the PAM by giving the
same response to all items, following guidance by
Insignia Health who licences the measure). This left data
for 251 patients to be analysed. Demographics data for
these participants are presented in Table 1.
Of the 251 patients, 185 (74%) were female. Most
participants [n¼ 235 (94%)] were white British. The most
common diagnosis was RA (66% of participants). The
mean age of participants was 59.3 years (S.D. 12.7) and
mean disease duration was 14.5 years (S.D. 12.5). The
mean PAM score was 58.3 (S.D. 11.46) and scores
ranged between 33 and 90.7. Table 1 also provides in-
formation about the central tendency and spread of
other variables.
Table 2 presents the results of the univariable analy-
ses, testing potential associations between individual
factors and patient activation. Of the 29 factors that
were tested, 25 were found to have a significant associ-
ation with PAM and these were tested in the subsequent
multivariable analyses. Variables removed at this point
were disease duration, the timeline domain of the BIPQ,
the chance HLOC subscale and the powerful others
HLOC subscale.
Factors associated with patient activation scores
The results of the two multivariable analyses (the prelim-
inary regression and the final regression models) are
reported in Tables 3 and 4, respectively. The factors in-
cluded in the final regression model were self-efficacy
(RASE), sense of control over treatment (BIPQ) and two
domains of health literacy (HLQ subscales: ‘having suffi-
cient information to manage health’ and ‘understanding
health information enough to know what to do’).
TABLE 2 Univariable analyses testing the association between patient activation and candidate factors (explanatory
variables)
Explanatory variables Spearman’s rank correlation coefficient P-value
Age (years) 0.14 0.03
Disease duration (years) 0.03 0.59
Physical disability (HAQ) 0.36 <0.01









Personal control 0.29 <0.01
Treatment control 0.30 <0.01
Identity 0.31 <0.01
Coherence 0.24 <0.01
Emotional representation 0.30 <0.01
Illness concern 0.36 <0.01
Health literacy (HLQ)
Feeling understood 0.27 <0.01
Sufficient information 0.48 <0.01
Actively managing 0.41 <0.01
Social support 0.33 <0.01
Appraisal 0.38 <0.01
Ability to engage 0.33 <0.01
Navigating healthcare 0.30 <0.01
Ability to find information 0.41 <0.01
Knowing what to do 0.42 <0.01
Pain intensity (NRS) 0.33 <0.01
Fatigue intensity (NRS) 0.31 <0.01
Positive affect (PANAS) 0.41 <0.01
Negative affect (PANAS) 0.33 <0.01
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TABLE 3 Factors associated with patient activation: preliminary multivariable model
Model Explanatory variables B (unstandardized) 95% CI P-value
1 R2¼0.128 (R2 change 128)
Age 0.030 0.139, 0.079 0.586
Physical disability (HAQ) 6.127 8.251, 4.002 <0.001
2 R2¼0.340 (R2 change 0.212)
Age 0.069 0.164, 0.027 0.158
Physical disability (HAQ) 4.349 6.243, 2.455 0.000
Self-efficacy (RASE) 0.354 0.275, 0.432 <0.001
3 R2¼0.348 (R2 change 0.008)
Age 0.072 0.170, 0.026 0.147
Physical disability (HAQ) 4.040 5.964, 2.115 <0.001
Self-efficacy (RASE) 0.337 0.256, 0.418 <0.001
Internal HLOC 0.110 0.091, 0.311 0.282
Doctors HLOC 0.242 0.135, 0.619 0.208
4 R2¼0.410 (R2 change 0.062)
Age 0.111 0.209, 0.013 0.026
Physical disability (HAQ) 2.674 5.093, 0.254 0.030
Self-efficacy (RASE) 0.269 0.184, 0.355 <0.001
Internal HLOC 0.071 0.128, 0.271 0.481
Doctors HLOC 0.205 0.180, 0.589 0.295
BIPQ_1 Consequences 0.575 1.480, 0.331 0.212
BIPQ_3 Personal control 0.276 0.316, 0.867 0.360
BIPQ_4 Treatment control 0.596 0.088, 1.279 0.087
BIPQ_5 Identity 0.344 0.583, 1.272 0.465
BIPQ_6 Illness concern 0.370 0.983, 0.243 0.235
BIPQ_7 Coherence 0.773 0.165, 1.382 0.013
BIPQ_8 Emotional response 0.129 0.718, 0.460 0.666
5 R2¼0.493 (R2 change 0.084)
Age 0.070 0.165, 0.026 0.151
Physical disability (HAQ) 1.671 4.093, 0.750 0.175
Self-efficacy (RASE) 0.153 0.058, 0.248 0.002
Internal HLOC 0.157 0.042, 0.356 0.121
Doctors HLOC 0.209 0.170, 0.589 0.278
BIPQ_1 Consequences 0.546 1.407, 0.316 0.213
BIPQ_3 Personal control 0.135 0.452, 0.721 0.651
BIPQ_4 Treatment control 0.780 0.094, 1.465 0.026
BIPQ_5 Identity 0.344 0.552, 1.240 0.450
BIPQ_6 Illness concern 0.309 0.898, 0.280 0.302
BIPQ_7 Coherence 0.008 0.678, 0.661 0.981
BIPQ_8 Emotional response 0.038 0.557, 0.633 0.899
HLQ Feeling understood 0.874 3.240, 1.491 0.467
HLQ Sufficient information 4.113 0.638, 7.588 0.021
HLQ Actively managing 1.649 1.415, 4.712 0.290
HLQ Social support 0.567 2.082, 3.216 0.673
HLQ Appraisal 1.980 0.807, 4.767 0.163
HLQ Ability to engage 0.075 2.978, 3.128 0.961
HLQ Navigating healthcare 2.260 5.672, 1.151 0.193
HLQ Ability to find information 0.931 2.401, 4.262 0.582
HLQ Knowing what to do 4.908 1.776, 8.041 0.002
6 R2¼0.498 (R2 change 0.004)
Age 0.072 0.167, 0.024 0.139
Physical disability (HAQ) 1.664 4.147, 0.818 0.188
Self-efficacy (RASE) 0.155 0.061, 0.250 0.001
Internal HLOC 0.164 0.035, 0.364 0.106
Doctors HLOC 0.148 0.241, 0.537 0.454
BIPQ_1 Consequences 0.607 1.477, 0.262 0.170
BIPQ_3 Personal control 0.123 0.467, 0.712 0.682
BIPQ_4 Treatment control 0.853 0.139, 1.566 0.019
BIPQ_5 Identity 0.371 0.609, 1.352 0.456
BIPQ_6 Illness concern 0.310 0.899, 0.280 0.301
(continued)
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The final regression model accounted for 40.4%
(R2¼ 0.404) of the variance in patient activation within
this sample [F(4, 246)¼ 41.66, P< 0.001]. Self-efficacy,
perceptions of controlling the illness with treatment and
HLQ domains 2 (having sufficient information to manage
my health) and 9 (understanding health information
enough to know what to do) were significantly associ-
ated with patient activation in participants.
Discussion
This study aimed to understand factors associated with
patient activation in participants with IA. Factors that
were significantly associated with patient activation
were self-efficacy, illness perceptions related to treat-
ment control and two dimensions of health literacy.
Overall, patient activation (average PAM score) in this
study was higher than published findings from
participants with COPD [16] but lower than the scores of
older adults with functional difficulties or employees
recruited from two companies in the USA [32, 33].
Participants in our study had lower average PAM scores
than those reported by Oliveira et al. [18] in a Brazilian
study. While Oliveira et al. [18] observed the relationship
between functional disability and patient activation, our
study findings did not support this relationship.
The distribution of PAM scores across the sample
demonstrates a range of experience and skills that par-
ticipants have to manage their health. The lack of a sta-
tistically significant association between PAM scores
and disease duration means that it is possible that
some patients would benefit from support to self-
manage, even after living with their condition for many
years. This is particularly relevant with long-term rheu-
matic conditions, where people may experience fluctua-
tions in their physical health as well as their ability and
TABLE 3 Continued
Model Explanatory variables B (unstandardized) 95% CI P-value
BIPQ_7 Coherence 0.096 0.777, 0.585 0.782
BIPQ_8 Emotional response 0.025 0.592, 0.642 0.936
HLQ Feeling understood 0.592 2.997, 1.813 0.628
HLQ Sufficient information 3.880 0.373, 7.387 0.030
HLQ Actively managing 1.602 1.464, 4.668 0.304
HLQ Social support 0.291 2.395, 2.977 0.831
HLQ Appraisal 2.059 0.763, 4.880 0.152
HLQ Ability to engage 0.146 3.248, 2.956 0.926
HLQ Navigating healthcare 2.232 5.643, 1.180 0.199
HLQ Ability to find information 1.334 2.068, 4.737 0.440
HLQ Knowing what to do 5.055 1.916, 8.194 0.002
Fatigue severity NRS 0.459 1.181, 0.262 0.211
Pain severity NRS 0.416 0.379, 1.210 0.304
7 R2¼ .499 (R2 change 0.001)
Age 0.072 0.170, 0.026 0.149
Physical disability (HAQ) 1.609 4.119, 0.902 0.208
Self-efficacy (RASE) 0.153 0.058, 0.249 0.002
Internal HLOC 0.164 0.036, 0.364 0.108
Doctors HLOC 0.143 0.248, 0.534 0.472
BIPQ_1 Consequences 0.605 1.479, 0.268 0.173
BIPQ_3 Personal control 0.128 0.465, 0.720 0.671
BIPQ_4 Treatment control 0.838 0.120, 1.557 0.022
BIPQ_5 Identity 0.368 0.618, 1.353 0.463
BIPQ_6 Illness concern 0.301 0.894, 0.292 0.318
BIPQ_7 Coherence 0.105 0.790, 0.580 0.763
BIPQ_8 Emotional response 0.077 0.585, 0.739 0.819
HLQ Feeling understood 0.515 2.951, 1.921 0.677
HLQ Sufficient information 3.931 0.405, 7.458 0.029
HLQ Actively managing 1.262 2.087, 4.610 0.459
HLQ Social support 0.167 2.574, 2.908 0.905
HLQ Appraisal 2.117 0.731, 4.965 0.144
HLQ Ability to engage 0.138 3.253, 2.977 0.930
HLQ Navigating healthcare 2.273 5.705, 1.159 0.193
HLQ Ability to find information 1.335 2.083, 4.752 0.442
HLQ Knowing what to do 4.990 1.824, 8.156 0.002
Fatigue severity NRS 0.443 1.171, 0.285 0.231
Pain severity NRS 0.422 0.388, 1.231 0.306
Positive affect (PANAS) 0.043 0.130, 0.215 0.627
Negative affect (PANAS) 0.014 0.210, 0.181 0.885
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willingness to actively self-manage. This also has impli-
cations for services stratifying self-management support
according to levels of patient activation, as measured
using the PAM.
The contribution of self-efficacy to patient activation
reflects the importance of the belief that participants
could carry out behaviours relevant to their health. This is
not surprising, given that self-efficacy is one of the most
targeted concepts in self-management research and has
been identified as amenable to intervention and a mecha-
nism by which self-management interventions for long-
term conditions can benefit patients [34, 35]. Self-efficacy
is amenable to intervention through mastering experien-
ces via the setting and achieving of goals or from vicari-
ous experience [36]. It has previously been targeted in
self-management rheumatology interventions [37]. This
contributes to the argument that increasing patients’ con-
fidence and belief in their ability to carry out activities re-
lated to their health increases their willingness to do so
as well as their perseverance when faced with a chal-
lenge. The relevance of health beliefs, specifically the
sense that participants felt their condition could be con-
trolled by treatment, suggests that developing this confi-
dence and sense of control in clinics could have positive
implications for self-management.
Research in other health conditions has confirmed the
contribution that health literacy makes to patient activa-
tion [23]. Reviewing, assessing and helping patients to
develop health literacy skills is clearly a key component
of supporting them to actively manage their long-term
condition. This requires further examination, and health
literacy training at a broader, population level may be a
direction for future research. Given that research has
identified that health literacy is related to health inequal-
ities (unfair and avoidable differences in the health of dif-
ferent sections of the population), it is a particularly
valuable psychosocial concept to target in interventions
[38, 39].
A notable finding in our data was that positive and neg-
ative affect (captured using the PANAS) was not
associated with patient activation. Other personal factors
were more important correlates of patient activation. This
suggests that these other variables may be more impor-
tant to patient activation in rheumatology than the prevail-
ing model, which is not health condition specific [12].
Our findings add weight to the roles of self-efficacy
and health literacy in patient activation. This indicates
that patient activation interventions could usefully focus
on training patients in determining how to seek out dif-
ferent types of support for long-term conditions, how to
respond to flare-ups and setbacks and when and how
to gather information and advice from trusted sources.
Strengths
This study is one of the first to investigate factors asso-
ciated with patient activation in a UK rheumatology pop-
ulation. Another strength was the multidisciplinary input
into the design of the survey, including the patient voice,
as well as input from psychology, nursing and statistics.
Limitations
A challenge in this study was that outcome measures
are often written in a way that renders them inaccessible
to people with low health literacy [40]. This could mean
that people with low levels of health literacy were more
likely to decline participation. It is possible that only
more activated patients participate in research in gen-
eral. Therefore selection bias, and self-selection bias in
particular, cannot be ruled out. Analysis of the BIPQ
domains as separate variables alongside other candi-
date factors in the multivariable analyses meant that the
statistical power in the preliminary multivariable analysis
was somewhat reduced. However, the final model was
appropriately powered.
Conclusion
Self-efficacy, health literacy and health beliefs related to
treatment control are significantly associated with
TABLE 4 Factors associated with patient activation: final multivariable model
Model Explanatory variables B (unstandardized) 95% CI P-value
1 R2¼0.266 (R2 change 0.266)
Self-efficacy (RASE) 0.388 0.307, 0.468 <0.001
2 R2¼0.297 (R2 change 0.032)
Self-efficacy (RASE) 0.358 0.277, 0.439 <0.001
BIPQ Treatment control 1.086 0.448, 1.725 0.001
3 R2¼0.357 (R2 change 0.060)
Self-efficacy (RASE) 0.271 0.185, 0.356 <0.001
BIPQ_4 Treatment control 0.662 0.025, 1.299 0.042
HLQ Sufficient information 6.784 3.991, 9.577 <0.001
4 R2¼0.404 (R2 change 0.047)
Self-efficacy (RASE) 0.226 0.141, 0.310 <0.001
BIPQ_4 Treatment control 0.738 0.123, 1.354 0.019
HLQ Sufficient information 5.111 2.315, 7.908 <0.001
HLQ Knowing what to do 5.004 2.763, 7.244 <0.001
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patient activation in IA. Positive and negative affect
were not associated with patient activation and future
research in rheumatology populations should investigate
this further. Future studies should focus on identifying
appropriate forms of intervention that target these varia-
bles and determine the acceptability of these interven-
tions to patients and other stakeholders.
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